◀ Back to BCL10

BCL10 — TCF25

Text-mined interactions from Literome

Sevilla et al., Mol Cell Biol 1999 : The bcl-x promoter contains potential Ets binding sites, and we show that the transcription factor , Ets2, first identified by its sequence identity to v-ets of the E26 retrovirus, can transactivate the bcl-x promoter
Tamatani et al., J Biol Chem 1999 : To examine the possible involvement of a transcription factor , NFkappaB, in the regulation of Bcl-2 and Bcl-x expression in TNF treated neurons, an adenoviral vector capable of expressing a mutated form of IkappaB was used to infect neurons prior to TNF treatment
Glasgow et al., Neurochem Res 2000 (Neurodegenerative Diseases) : Key in these cascades is the activation of the caspase and Bcl-family of proteins by the NF-kappaB transcription factor
Greten et al., Gastroenterology 2002 (Carcinoma, Ductal, Breast...) : Inhibition of either transcription factor alone leads to Bcl-x ( L ) down-regulation in transient transfection assays
Xie et al., Crit Rev Immunol 2006 : However, TCF-1 and ROR gamma t by themselves are not sufficient to stimulate Bcl-xL expression
Gyamfi et al., J Pharmacol Exp Ther 2008 (Inflammation...) : Furthermore, signal transducer and activator of transcription factor ( STAT ) 3 and associated Bcl-xL induction was observed in ethanol fed wild-type mice but not in ethanol fed hepatocyte RXRalpha-deficient mice
Chen et al., J Bone Miner Res 2010 : Application of GATA-3 small interfering siRNA into osteoblasts decreased the levels of this transcription factor and simultaneously inhibited Bcl-X ( L ) mRNA synthesis